Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROC Trial in Rheumatoid Arthritis
NCT01000441Phase 4Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Dec 2009
- Primary completion
- Aug 2013
- Modality
- Antibody Conjugates, Engineered Antibody Formats, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 4 trial of infliximab, etanercept, adalimumab, abatacept, rituximab in rheumatoid arthritis (RA), sponsored by Strasbourg University Hospital. Started Dec 2009; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01000441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01000441.